Atlas Trials

Hypercholesteremia

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hypercholesteremia

RecordFirmDate
The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia (NCT05164185)Karolinska Institutet2020-09-02
Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes (NCT02850224)Henry Ford Health System2017-04-20
A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins (NCT02634151)NeuroBo Pharmaceuticals Inc.2016-11-01
Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1) (NCT02722408)NeuroBo Pharmaceuticals Inc.2016-06-01
Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health (NCT01890889)Integrative Health Technologies, Inc.2013-07-01
Pattern of Statins Use in Catalonia (NCT01477944)AstraZeneca2012-02-01
Effects of Limicol on LDL-cholesterol (NCT01354327)Lescuyer Laboratory2008-12-01
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients (NCT00688454)AstraZeneca2007-02-01
Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) (NCT00376584)Merck Sharp & Dohme LLC2006-07-01
Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event (NCT00347217)AstraZeneca2006-02-01
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease (NCT00329160)AstraZeneca2005-10-01
Phytosterol Supplementation and Cardiovascular Risk (NCT00153738)The Cooper Institute2004-03-01
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy (NCT00239330)AstraZeneca2003-06-01
Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers (NCT02587416)NeuroBo Pharmaceuticals Inc.2002-11-01
A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) (NCT00225589)AstraZeneca2002-08-01
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque (NCT00408382)Astellas Pharma Inc

Track Hypercholesteremia automatically

Every clearance here is in the API, with alerts when new ones post.